Back to search results
NCT07498322

Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System

Not Yet Recruiting
NAAges 16+InterventionalHealth services
University of Illinois at Chicago
~271,031 participants
Updated 2026-04-01 on ClinicalTrials.gov
What's tested:OUD screeningMOUDContinuity of care

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of people screened for OUD
Measured over Rolling measure of annual rates (12 months) measured over the implementation period.
+2 more outcomes measured

Conditions

Opiod Use Disorder

Explore related trials

Opioid Use Disorder

Where it's being run

1 sites across 1 states
Illinois1

Study leadership

  • Niranjan S. Karnik, MD, PhD · PRINCIPAL_INVESTIGATOR · UIC, College of Medicine
  • Neeraj Chhabra, MD · PRINCIPAL_INVESTIGATOR · UIC, College of Medicine

Who to contact

Niranjan S. Karnik, MD, PhD
[email protected]
(312) 273-0185
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participant must be a patient seen at the University of Illinois Hospital and Clinics
Adults and adolescents age 16 or older

What this trial measures

  • Number of people screened for OUDRolling measure of annual rates (12 months) measured over the implementation period.

    Aggregate rate of data-driven OUD screening across the health system

  • Continuity of care for patients with OUD30 days and 12 months

    Continuity of care will be assessed through appointment follow-up and completion of referral to the next care site within 30 days.

  • Utilization of MOUD across the health systemBaseline and 12 months

    MOUD use will be measured as the number of patients actively on MOUD as a proportion of all patients within the health system and of those with documented OUD within the health system as defined by International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes.